GO:0043923 host-mediated activation of viral transcription: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043923 describes how a host cell initiates, promotes, or enhances viral transcription, the synthesis of RNA on a viral DNA or RNA template.
• Host-mediated activation of viral transcription is a biological_process that sits at the interface of host cell signaling, chromatin remodeling, and viral gene expression.
• Host post-translational modifications (PTMs) such as phosphorylation, SUMOylation, and ubiquitination are central switches that can either activate or restrict viral transcription.
• Key host factors include RNA polymerase II subunits, transcription factors such as NF-kB and IRF7, chromatin remodelers, and RNA quality control proteins.
• Dysregulation of this process contributes to viral pathogenesis, immune-mediated disease, and virus-associated cancers such as Kaposi's sarcoma.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect which host genes causally activate viral transcription.
Description
GO:0043923, host-mediated activation of viral transcription, is a Gene Ontology biological_process term that captures a fundamental host-pathogen interaction: the host cell actively initiates, promotes, or enhances the normal execution of viral transcription. In this process, the host provides transcription machinery, signaling cues, and chromatin context that allow viral genomes to be transcribed into RNA, whether the viral template is DNA or RNA. This term is distinct from viral self-activation because the emphasis is on host-encoded factors that positively regulate viral transcription. Understanding GO:0043923 is critical for virology, immunology, and antiviral drug discovery because many viruses hijack host transcription factors and RNA processing pathways to amplify their gene expression. Host-mediated activation of viral transcription is also relevant to vaccine design and gene therapy, where unintended activation of viral or viral-vector transcription can alter safety and efficacy profiles. Recent studies show that host PTMs, including SUMOylation and phosphorylation, dynamically tune the activity of both host and viral transcription factors during infection. Therefore, GO:0043923 provides a structured framework for researchers to annotate, compare, and experimentally perturb host-dependent viral transcription programs.
host-mediated activation of viral transcription At A Glance
| GO ID | GO:0043923 |
|---|---|
| GO term | host-mediated activation of viral transcription |
| Ontology | biological_process |
| Synonym | positive regulation by host of viral transcription; positive regulation of viral transcription by host |
| Major function | Host-driven initiation, promotion, or enhancement of viral RNA synthesis from viral DNA or RNA templates |
| Directionality | Positive regulation (activation) of viral transcription by host factors |
| Taxonomic scope | Applies to host-virus systems across eukaryotes and prokaryotes where host factors enhance viral transcription |
| Related processes | Host PTMs, RNA quality control, innate immune signaling, chromatin remodeling |
What Is GO:0043923?
In our own words, GO:0043923 (host-mediated activation of viral transcription) is the process by which a host organism positively regulates the synthesis of viral RNA from a viral DNA or RNA template. The host does not merely permit viral transcription; it actively initiates, promotes, or enhances it through host-encoded transcription factors, RNA polymerases, chromatin modifiers, and signaling pathways. This term is a biological_process and is synonymous with positive regulation by host of viral transcription and positive regulation of viral transcription by host.
Why Is host-mediated activation of viral transcription Important in Cell Biology?
GO:0043923 matters because it defines the host-side control point that viruses exploit to amplify their gene expression, and it is a major determinant of viral fitness, immune evasion, and disease outcome. Many host proteins that activate viral transcription are also central nodes in innate immunity and cell stress responses, so perturbing them can shift the balance between viral clearance and immunopathology. In clinical and translational research, host-mediated activation of viral transcription is a target for antiviral strategies and a variable that influences the performance of viral vectors in gene therapy.
• Defines how host transcription machinery and signaling pathways are co-opted to drive viral RNA synthesis.
• Explains why host PTMs such as SUMOylation and phosphorylation can either promote or restrict viral transcription.
• Links host RNA quality control and processing pathways to the temporal expression of viral late genes.
• Provides a mechanistic basis for immune-mediated pathology when host activation of viral transcription is unchecked.
• Helps interpret transcriptomic changes in virus-infected hosts, including plant and animal systems.
• Supports antiviral target discovery by identifying host dependency factors required for viral transcription.
• Informs the design of safer viral vectors by predicting host-driven transcriptional activation.
• Enables comparative studies of DNA and RNA viruses that converge on host transcription activation.
• Guides CRISPR screens to separate host activators from host restriction factors.
• Connects viral transcription activation to cancer biology, as seen in Kaposi's sarcoma-associated herpesvirus.
What Happens During host-mediated activation of viral transcription?
Host factor recruitment to viral templates
In simple terms: The host cell brings its own transcription proteins to the viral genome.
During host-mediated activation of viral transcription, host-encoded transcription factors and RNA polymerase complexes are recruited to viral promoter or enhancer regions. This recruitment can be direct, through sequence-specific DNA-binding proteins, or indirect, through protein-protein interactions with viral proteins. Host PTMs such as phosphorylation and SUMOylation regulate the assembly and activity of these transcription complexes. The outcome is enhanced synthesis of viral RNA from the viral template.
Chromatin remodeling and template accessibility
In simple terms: The host opens up the viral DNA so it can be read.
For DNA viruses, host chromatin remodelers and histone-modifying enzymes alter nucleosome positioning on viral genomes to make promoters accessible. Host-mediated activation of viral transcription therefore depends on the balance between activating and repressive chromatin marks. Kaposi's sarcoma-associated herpesvirus manipulates host RNA quality control and chromatin-associated pathways to fine-tune late gene expression. These events illustrate how host factors control the temporal program of viral transcription.
Signaling-dependent enhancement of viral transcription
In simple terms: Host immune signals can accidentally boost viral gene expression.
Host signaling pathways, including NF-kB and interferon-related cascades, can be activated during infection and subsequently enhance viral transcription. For example, TGEV infection activates pro-inflammatory signaling via the YY1/HSP40/NF-kB pathway in intestinal epithelial cells and organoids. IRF7-dependent type I interferon production in STAT1 knockout mice infected with lymphocytic choriomeningitis virus induces lethal immune-mediated disease, highlighting how host signaling can drive pathogenic outcomes linked to viral transcription activation. These findings show that host-mediated activation of viral transcription is often a downstream consequence of innate immune activation.
Post-translational modifications as molecular switches
In simple terms: Small chemical tags on host proteins decide whether viral transcription is turned on.
Host-mediated post-translational modifications (PTMs) such as ubiquitination, SUMOylation, and phosphorylation regulate the stability, localization, and activity of transcription factors that act on viral genomes. SUMOylation of host and viral proteins can alter effector-like potential and pathogenic adaptation, as reviewed in the context of Cas9 and beyond. These PTM switches determine whether host-mediated activation of viral transcription proceeds or is restricted.
RNA processing and quality control coupling
In simple terms: The host also checks and processes the viral RNA as it is made.
Host RNA quality control pathways are intertwined with viral transcription activation, influencing the stability and export of viral transcripts. Kaposi's sarcoma-associated herpesvirus fine-tunes the temporal expression of late genes by manipulating a host RNA quality control pathway. This coupling means that host-mediated activation of viral transcription is not only about making RNA but also about ensuring its proper processing. Dysregulation of these steps can alter viral gene expression programs and pathogenesis.
Key Genes Involved in GO:0043923 host-mediated activation of viral transcription
The following host genes and proteins have been implicated in host-mediated activation of viral transcription or in closely related regulatory mechanisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RELA (NF-kB p65) | Host transcription factor that can enhance viral promoter activity | Central node in inflammatory signaling during viral infection |
| IRF7 | Host transcription factor driving type I interferon production | Linked to immune-mediated disease in STAT1-deficient models |
| STAT1 | Host signal transducer and transcription activator | Modulates host antiviral and inflammatory transcription programs |
| YY1 | Host transcription factor involved in pro-inflammatory signaling | Implicated in TGEV-induced signaling in intestinal epithelial cells |
| HSP40 (DNAJB1) | Host chaperone supporting signaling complexes | Participates in YY1/HSP40/NF-kB pathway during TGEV infection |
| SUMO1/2/3 | Host small ubiquitin-like modifiers | Regulate transcription factor activity and viral adaptation |
| UBE2I (UBC9) | Host SUMO-conjugating enzyme | Controls SUMOylation of host and viral proteins |
| POLR2A | Host RNA polymerase II largest subunit | Core enzyme for synthesis of viral RNA from DNA templates |
| CDK9 | Host kinase regulating RNA polymerase II elongation | Potential modulator of viral transcription elongation |
| EP300 (p300) | Host histone acetyltransferase | Chromatin remodeling at viral promoters |
| CREBBP (CBP) | Host histone acetyltransferase | Coactivator for host and viral transcription factors |
| HDAC1/2 | Host histone deacetylases | Balance activating and repressive chromatin marks on viral genomes |
| XRN1 | Host 5'-3' exoribonuclease in RNA quality control | Influences viral late gene expression via RNA quality control |
| UPF1 | Host RNA helicase in nonsense-mediated decay | Couples RNA quality control to viral transcript fate |
| DDX58 (RIG-I) | Host cytosolic RNA sensor | Indirectly shapes transcriptional responses during infection |
| IFIH1 (MDA5) | Host cytosolic RNA sensor | Activates signaling that can modulate viral transcription |
| MAVS | Host mitochondrial antiviral signaling adaptor | Links sensing to transcription factor activation |
How Is host-mediated activation of viral transcription Regulated?
Host-mediated activation of viral transcription is regulated at multiple levels, including post-translational modifications of host and viral proteins, chromatin state, and innate immune signaling. SUMOylation and phosphorylation can switch transcription factors between active and inactive states, thereby tuning the efficiency of viral RNA synthesis. Host RNA quality control pathways also regulate the temporal expression of viral late genes, ensuring that transcription activation is coordinated with transcript processing. In addition, signaling pathways such as NF-kB and interferon cascades can either promote or restrict viral transcription depending on the infection context.
host-mediated activation of viral transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IRF7 | Immune-mediated lethal disease during LCMV infection | STAT1 knockout mouse model |
| STAT1 | Susceptibility to viral infection and immunopathology | STAT1-deficient mice and cell lines |
| YY1 | TGEV-induced intestinal inflammation | Intestinal epithelial cells and organoids |
| HSP40 (DNAJB1) | Pro-inflammatory signaling during coronavirus infection | Intestinal epithelial cells and organoids |
| XRN1 | KSHV late gene expression and viral persistence | KSHV-infected cell culture models |
Virus-associated cancers
Kaposi's sarcoma-associated herpesvirus manipulates host RNA quality control and transcription regulatory pathways to fine-tune late gene expression, a process linked to viral persistence and oncogenesis. Host-mediated activation of viral transcription can therefore contribute to the expression of viral oncogenes and to cancer development.
Immune-mediated pathology
In STAT1-deficient mice infected with lymphocytic choriomeningitis virus, IRF7-dependent type I interferon production induces lethal immune-mediated disease, illustrating how host transcriptional activation during infection can cause severe pathology. This highlights the dual role of host-mediated activation of viral transcription in both antiviral defense and immunopathology.
Inflammatory and enteric disease
TGEV infection activates pro-inflammatory signaling via the YY1/HSP40/NF-kB pathway in intestinal epithelial cells and organoids, linking host-mediated activation of viral transcription to intestinal inflammation. Such mechanisms may contribute to enteric disease severity and barrier dysfunction.
Antiviral resistance and treatment failure
Host-mediated activation of viral transcription can influence how efficiently viruses replicate under antiviral pressure, including mechanisms of resistance and delayed host responses. Understanding these host dependencies may inform combination therapies that target both viral and host factors.
From host-mediated activation of viral transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a host gene required for viral transcription activation? | CRISPR knockout cell line followed by viral infection and RNA-seq |
| Does a specific phosphorylation site control host-mediated activation? | Point-mutation knock-in of phospho-dead or phospho-mimetic residues |
| Does a host factor directly bind viral promoters? | Tagged knock-in for ChIP-seq or CUT&RUN |
| Can overexpression of a host factor enhance viral transcription? | Overexpression cell model with viral reporter assay |
| Which host pathways regulate viral late gene expression? | RNA quality control knockout models with KSHV infection |
| How does host signaling shape immunopathology? | STAT1 knockout mouse models with LCMV infection |
How to Study the host-mediated activation of viral transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Viral and host transcript abundance | Quantifying host-mediated activation of viral transcription |
| Proteomics / PTM profiling | Protein abundance and post-translational modifications | Identifying SUMOylation and phosphorylation switches |
| ChIP-seq / CUT&RUN | Transcription factor occupancy on viral and host DNA | Mapping host factor binding at viral promoters |
| ATAC-seq | Chromatin accessibility | Assessing viral genome accessibility during infection |
| CRISPR knockout screening | Host gene requirement for viral transcription | Discovering host dependency factors |
| CRISPR point-mutation knock-in | Effect of specific residues on host factor function | Testing phospho-dead or SUMO-deficient mutants |
| Overexpression assays | Gain-of-function effects on viral transcription | Validating host activators of viral transcription |
| Reporter virus assays | Viral promoter activity | Measuring activation of viral transcription in live cells |
Transcriptomic profiling of viral and host RNA
RNA-seq and related transcriptomic methods measure changes in viral and host gene expression during infection, allowing researchers to quantify host-mediated activation of viral transcription. In tomato brown rugose fruit virus-infected tomato, transcriptomic changes were assessed in response to low-dose gamma irradiation, demonstrating the utility of RNA-seq in plant-virus systems. These approaches can identify host genes whose expression correlates with viral transcription activation.
Post-translational modification profiling
Proteomic and PTM-specific workflows detect phosphorylation, SUMOylation, and ubiquitination events on host and viral proteins. Such methods are essential to determine how host PTMs regulate transcription factor activity during viral infection. They can reveal dynamic switches that control host-mediated activation of viral transcription.
Chromatin and transcription factor occupancy assays
ChIP-seq, CUT&RUN, and ATAC-seq measure transcription factor binding and chromatin accessibility at viral promoters. These assays help define how host chromatin remodelers and transcription factors access viral genomes. They are particularly useful for DNA viruses with complex temporal gene expression programs.
Functional perturbation with CRISPR and RNAi
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of host genes in viral transcription activation. Pooled CRISPR screens can identify host dependency factors and restriction factors at scale. These functional approaches complement observational transcriptomic and proteomic data.
How CRISPR Can Be Used to Study GO:0043923 host-mediated activation of viral transcription
Knockout
CRISPR knockout of candidate host genes is used to test whether they are required for host-mediated activation of viral transcription. By comparing viral RNA levels in knockout versus wild-type cells, researchers can identify host dependency factors. This approach is scalable to pooled screens for genome-wide discovery.
Point Mutation
CRISPR point-mutation knock-in allows precise editing of host genes to test the role of specific residues, such as phosphorylation or SUMOylation sites, in viral transcription activation. These models help distinguish between structural and regulatory functions of host proteins. They are particularly valuable when complete knockout is lethal or pleiotropic.
Knock-in
Tagged knock-in of host genes enables endogenous protein localization and interaction studies during viral infection. For example, epitope-tagged transcription factors can be used for ChIP-seq to map binding at viral promoters. Knock-in models preserve physiological expression levels, improving relevance to host-mediated activation of viral transcription.
Overexpression
Overexpression of host transcription factors or signaling proteins can test whether they are sufficient to enhance viral transcription. These models are useful for gain-of-function studies and for validating host activators identified in screens. Overexpression systems can also be combined with viral reporter assays for quantitative readouts.
How EDITGENE Supports host-mediated activation of viral transcription Research
Researchers studying host-mediated activation of viral transcription-related genes often need to determine whether a candidate gene is causally involved in enhancing viral RNA synthesis or is merely a bystander in the infection response. This requires precise, reproducible genetic models that can isolate the contribution of individual host factors. EDITGENE provides end-to-end CRISPR services to generate such models and to support functional genomics at scale.
Contact EDITGENE today to design your custom CRISPR model for host-mediated activation of viral transcription research.
Frequently Asked Questions About host-mediated activation of viral transcription
What is GO:0043923 host-mediated activation of viral transcription?
GO:0043923 is a Gene Ontology biological_process term describing how a host organism initiates, promotes, or enhances viral transcription, the synthesis of RNA from a viral DNA or RNA template.
What genes are involved in host-mediated activation of viral transcription?
Host genes such as RELA, IRF7, STAT1, YY1, HSP40, SUMO pathway components, POLR2A, CDK9, EP300, CREBBP, HDAC1/2, XRN1, and UPF1 have been implicated in regulating viral transcription.
How does the host activate viral transcription?
The host recruits transcription factors and RNA polymerase to viral templates, remodels viral chromatin, and uses signaling pathways and post-translational modifications to enhance viral RNA synthesis.
Why is host-mediated activation of viral transcription important for disease?
It can drive viral replication, immune-mediated pathology, and virus-associated cancers, as seen in KSHV and LCMV infection models.
What experimental methods study host-mediated activation of viral transcription?
RNA-seq, proteomics, ChIP-seq, ATAC-seq, CRISPR knockout screens, point-mutation knock-in, and overexpression assays are commonly used.
Can CRISPR be used to study host-mediated activation of viral transcription?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of host genes in viral transcription activation.
What is the difference between host-mediated activation and viral self-activation of transcription?
Host-mediated activation emphasizes host-encoded factors that positively regulate viral transcription, whereas viral self-activation would rely primarily on viral proteins.
Which viruses are linked to GO:0043923?
Examples include Kaposi's sarcoma-associated herpesvirus, lymphocytic choriomeningitis virus, TGEV, and tomato brown rugose fruit virus, among others.
How do post-translational modifications regulate host-mediated activation of viral transcription?
Phosphorylation, SUMOylation, and ubiquitination alter the activity and stability of host and viral transcription factors, thereby tuning viral RNA synthesis.
What cell models are suitable for studying host-mediated activation of viral transcription?
Knockout, point-mutation knock-in, tagged knock-in, and overexpression cell models, as well as organoid and mouse models, are suitable depending on the research question.
Conclusion
GO:0043923 host-mediated activation of viral transcription is a central biological_process that explains how host cells actively promote viral RNA synthesis through transcription factor recruitment, chromatin remodeling, signaling, and post-translational modifications. Its relevance spans viral pathogenesis, immune-mediated disease, and virus-associated cancers, making it a high-value target for mechanistic and translational research. By combining CRISPR knockout, point-mutation, knock-in, overexpression, and library screening approaches, researchers can causally dissect the host factors that drive this process. EDITGENE supports these efforts with publication-ready cell models and bioinformatics services tailored to host-virus transcription studies.
References
- 1. Kumar R et al.. 2020. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.. Int J Mol Sci 22(1) PMID: 33396899
- 2. Gao S et al.. 2026. TGEV infection activates pro‑inflammatory signaling via the YY1/HSP40/NF‑κB pathway in intestinal epithelial cells and organoids.. Vet Microbiol 316:110985 PMID: 41797175
- 3. Sahin U. 2026. Cas9 beyond CRISPR - SUMOylation, effector-like potential and pathogenic adaptation.. FEBS J 293(5):1285-1296 PMID: 40898426
- 4. Sharon AJ et al.. 2022. Restriction of Viral Replication, Rather than T Cell Immunopathology, Drives Lethality in Murine Norovirus CR6-Infected STAT1-Deficient Mice.. J Virol 96(6):e0206521 PMID: 35107369
- 5. Tokhmechi K et al.. 2026. Transcriptomic changes in tomato brown rugose fruit virus-infected tomato in response to low-dose gamma irradiation.. Sci Rep 16(1) PMID: 42156530
- 6. Rodríguez RA et al.. 2025. Mechanistic Insights into Adenovirus Resistance to UV: Dose-Dependent Repair and Delayed Suppression of Host DNA Damage Response.. Environ Sci Technol 59(49):26830-26839 PMID: 41326052
- 7. Ruiz JC et al.. 2020. Kaposi's Sarcoma-Associated Herpesvirus Fine-Tunes the Temporal Expression of Late Genes by Manipulating a Host RNA Quality Control Pathway.. J Virol 94(14) PMID: 32376621
- 8. Li W et al.. 2014. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.. J Virol 88(13):7578-88 PMID: 24760883
